AzTrials
AzTrials

Critical IllnessNCT05526105

Gastric US in ICU Patient

A study testing Gastric Ultrasound in people with Critical Illness and Surgery, run by Dartmouth-Hitchcock Medical Center at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This is a case series study using gastric ultrasound in critically ill patients to quantify gastric residual volumes to compare the efficacy of different NPO protocols. Read more about this study

Who is it for?
Ages 18 to 100 years
Conditions the study is for
Critical Illness, Surgery, Aspiration Pneumonia
What is being tested?
Gastric Ultrasound
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
3 Feb 2023to 3 Feb 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients age 18 or older, admitted to the ICU, requiring general anesthesia or sedation for a procedure with a pre-existing, cuffed endotracheal or tracheostomy tube. Most patients admitted to the ICU would be unable to consent.

Who cannot join

  • Known upper gastrointestinal anatomical problem that would prevent accurate estimation of gastric volume, gastric perforation, pregnancy beyond the first trimester.
  • Lack of a pre-existing, cuffed endotracheal or tracheostomy tube.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Dartmouth Hitchcock Medical Center

    Lebanon, New Hampshire, 03766

Other trials in United States

About this study

Official title: Gastric Ultrasound in Critically Ill Patients for Evaluation of Gastric Volume Residuals; A Comparison of NPO Protocols

This is a case series study using gastric ultrasound in critically ill patients to quantify gastric residual volumes to compare the efficacy of different NPO protocols.

Being tested
Gastric Ultrasound
Keywords
NPO Protocols, Intensive Care Unit, Gastric Ultrasound, Ultrasound, Surgical Intensive Care Unit, NPO, Nasogastric Tube, Orogastric Tube, Enteral Nutrition, Parenteral Nutrition, Gastric Residual Volume, Aspiration, Critical Illness Nutrition
Medical subject headings
Critical Illness, Pneumonia, Aspiration, Hyperphagia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Gastric UltrasoundDiagnostic test

    Gastric ultrasound in the supine and right lateral decubitus position for patients going for operative intervention with a protected airway.

Study groups in NCT05526105
Study groupRoleWhat they receive
Standard ASA NPO ProtocolExperimentalPatients will be made NPO at midnight prior to date of surgery.
Receives: Diagnostic Test: Gastric Ultrasound
Liberal Feeding ProtocolExperimentalPatients will be fed enterally up until call to OR at which time their stomachs will be decompressed with a pre-existing gastric tube.
Receives: Diagnostic Test: Gastric Ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gastric Residual Volumes

    Quantification of gastric residual volumes as measured in milliliters using antral cross-sectional areas and semi-quantitative gastric volumes using standardized grading scores.

    Measured: Within one hour of operative intervention.

Secondary outcomes (3)
  1. Comparison of two different NPO protocol populations

    Comparing standard ASA NPO protocol vs liberal, feed-up-until-call to OR protocol as defined by comparison of gastric volumes (mLs).

    Measured: Within four months of study completion, 16 months from study start

  2. Peri-operative aspiration events

    Number of aspiration events per number of operative interventions.

    Measured: Within four months of study completion, 16 months from study start

  3. Estimation of the amount of enteral nutrition lost prior to surgery using the different NPO protocols

    Calculation of enteral nutrition held during NPO time in kilocalories.

    Measured: Zero to sixteen hours prior to surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Sep 2022
  2. Study start3 Feb 2023
  3. Primary completion3 Feb 2025
  4. Study completion3 Feb 2025

Why it stopped: Not enough resources (time and manpower) to run study.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Patients will be assigned to be NPO after midnight (standard protocol) or feed up until call to OR then decompressed (liberal protocol).
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05526105
Sponsor's protocol ID
STUDY02001249
Status last verified
Oct 2026
First submitted
15 Aug 2022
Last updated
20 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Gastric Ultrasound in people with Critical Illness and Surgery, run by Dartmouth-Hitchcock Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 20 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gastric Residual Volumes (time frame: Within one hour of operative intervention.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in